Roy Chaudhuri, Tista <br/><br/>
Tumor-Priming Smoothened Inhibitor Enhances Deposition and Efficacy of Cytotoxic Nanoparticles in a Pancreatic Cancer Model.  [electronic resource] 

 -  Molecular cancer therapeutics  Jan 2016 
 - 84-93 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1538-8514 
<br/><br/><label>Standard No.: </label>10.1158/1535-7163.MCT-15-0602  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--administration & dosage<br/>Capillary Permeability--drug effects<br/>Cell Line, Tumor<br/>Disease Models, Animal<br/>Doxorubicin--administration & dosage<br/>Drug Carriers<br/>Humans<br/>Liposomes<br/>Mice<br/>Nanoparticles<br/>Neovascularization, Pathologic--drug therapy<br/>Pancreatic Neoplasms--drug therapy<br/>Polyethylene Glycols--administration & dosage<br/>Receptors, G-Protein-Coupled--antagonists & inhibitors<br/>Smoothened Receptor<br/>Tumor Burden--drug effects<br/>Xenograft Model Antitumor Assays